adenosine monophosphate has been researched along with Neoplasms in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (34.04) | 18.7374 |
| 1990's | 1 (2.13) | 18.2507 |
| 2000's | 4 (8.51) | 29.6817 |
| 2010's | 14 (29.79) | 24.3611 |
| 2020's | 12 (25.53) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Džubák, P; Gurská, S; Hajdúch, M; Hejtmánková, K; Hocek, M; Lišková, B; Oždian, T; Pohl, R; Smoleń, S; Tichý, M; Tloušt'ová, E | 1 |
| Ignatev, K; Oleinik, E; Shibaev, M; Zhulai, G | 1 |
| Manavathi, B; Mishra, YG; Penugurti, V | 1 |
| Gong, C; He, T; Li, L; Li, X; Li, Y; Liang, X; Liu, X; Loh, XJ; Luo, Z; Qin, X | 1 |
| Bugno, J; Fu, YX; Han, C; Han, W; Huang, X; Jiang, X; Li, S; Liang, H; Lin, W; Piffko, A; Ting, JPY; Wang, J; Wang, L; Weichselbaum, RR; Xu, Z; Yang, K; Zheng, W | 1 |
| Chen, B; Fu, F; Liu, Y; Lu, J; Luo, N; Shen, H; Tan, KS; Wang, D; Wang, J; Wu, M; Wu, Z; Yao, Y; Zhou, S; Zhou, Y | 1 |
| Demaria, S; Golden, E; Stagg, J; Wennerberg, E | 1 |
| Goueli, SA; Hsiao, K | 1 |
| Dubyak, GR | 1 |
| Arcobello, J; Bakouny, Z; Choueiri, TK; de Lima Lopes, G; Doroshow, DB; Egan, PC; Farmakiotis, D; Fecher, LA; Friese, CR; Galsky, MD; Goel, S; Grivas, P; Gupta, S; Halfdanarson, TR; Halmos, B; Hawley, JE; Hsu, CY; Khaki, AR; Kuderer, NM; Lee, BJ; Lemmon, CA; Lyman, GH; Mishra, S; Olszewski, AJ; Painter, CA; Panagiotou, OA; Pennell, NA; Peters, S; Puc, MM; Revankar, SG; Rini, BI; Rivera, DR; Rubinstein, SM; Schapira, L; Schmidt, A; Schwartz, GK; Shah, DP; Shah, SA; Shyr, Y; Thompson, MA; Warner, JL; Wu, JT; Xie, Z; Yeh, AC; Zhu, H | 1 |
| Bollag, WB; Jung, J | 1 |
| Hardie, DG; Russell, FM | 1 |
| Printz, C | 1 |
| Gullón, P; Lara, MÁ; Obispo, B; Rogado, J; Serrano, G | 1 |
| Abdo, I; Abouelnaga, S; Al-Halfawy, A; El-Ansary, MG; Elhaddad, A; Elmeniawy, S; Hammad, M; Hassan, R; Khamis, N; Madeny, Y; Mansour, T; Shalaby, L; Sherief, N; Sidhom, I; Soliman, S; Zaki, I | 1 |
| Baek, KH; Bhang, DH; Choi, US; Kim, BG; Li, Q; Ryeom, S; Ryu, MO; Seo, KW; Song, YK; Youn, HY | 1 |
| Joolharzadeh, P; St Hilaire, C | 1 |
| Dong, K; Gao, ZW; Zhang, HZ | 1 |
| Du, X; Shi, J; Wu, D; Xu, B; Zhou, J; Zhou, N | 1 |
| Adams, PD; Labuschagne, CF; Maddocks, OD; Vousden, KH | 1 |
| Quintana, FJ; Robson, S; Takenaka, MC | 1 |
| Fernández-Real, JM; Menendez, JA; Oliveras-Ferraros, C; Vazquez-Martin, A | 1 |
| Barrett, CM; Coss, CC; Dalton, JT; Hurh, E; Li, CM; Lu, Y; Miller, DD; Narayanan, R | 1 |
| Azab, B; Bhutia, SK; Das, SK; Fisher, PB; Kegelman, TP; Lee, SG; Sarkar, D; Su, ZZ | 1 |
| Whiteside, TL | 1 |
| Cardaci, S; Ciriolo, MR; Filomeni, G | 1 |
| ALLISON, JB; CROSSLEY, ML; MCCOY, JR; WANNEMACHER, RW | 1 |
| CHAN, SK; KIZER, DE; McCOY, TA | 2 |
| FIALA, S; KASINSKY, HE | 1 |
| BOLOGNESI, M | 1 |
| WINNICK, T | 1 |
| HACKBARTH, DE; KANOF, NB; MARKS, IE; SAWICKY, HH | 1 |
| Caldas, C; Capella, G | 1 |
| Abraham, EH; Cho, SY; Engles, JM; Hilton, J; Polster, J; Wahl, RL | 1 |
| Hardie, DG; Towler, MC | 1 |
| Weber, G | 1 |
| Berezov, TT | 1 |
| Fishman, RF; Gercel, C; Rapaport, E | 1 |
| Gorkin, VZ | 1 |
| Catane, R; Evans, JT; Kaufman, JH; Mittelman, A; Nime, FA | 1 |
| Katakkar, SB; Khaliq, A; LePage, GA; Naik, SR | 1 |
| Nissenson, RA; Strewler, GJ | 1 |
| Raju, N; Robins, RK; Smee, DF; Vaghefi, MM | 1 |
| Houck, JC | 1 |
| Ramaiah, A | 1 |
16 review(s) available for adenosine monophosphate and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer.
Topics: Adenosine; Adenosine Deaminase; Adenosine Kinase; Adenosine Monophosphate; Humans; Inosine; Neoplasms; Tumor Microenvironment | 2022 |
AMPK: An odyssey of a metabolic regulator, a tumor suppressor, and now a contextual oncogene.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Animals; Energy Metabolism; Humans; Mice; Neoplasms; Oncogenes; Phosphorylation | 2022 |
The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy.
Topics: Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; DNA Damage; Humans; Neoplasms; Tumor Microenvironment | 2023 |
AMP-Activated Protein Kinase: Do We Need Activators or Inhibitors to Treat or Prevent Cancer?
Topics: Adenosine Monophosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Diabetes Mellitus, Type 2; DNA Damage; Energy Metabolism; Humans; Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; Tumor Suppressor Proteins | 2020 |
CD73 (Cluster of Differentiation 73) and the Differences Between Mice and Humans.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Clinical Trials as Topic; Disease Models, Animal; GPI-Linked Proteins; Humans; Inflammation; Joint Diseases; Mice, Knockout; Molecular Targeted Therapy; Neoplasms; Phenotype; Species Specificity; Thrombophilia; Tunica Media; Vascular Calcification; Vascular Diseases; Vascular Remodeling | 2019 |
The roles of CD73 in cancer.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Carcinogenesis; Cell Proliferation; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Mice; Neoplasms; Neovascularization, Pathologic | 2014 |
Regulation of the T Cell Response by CD39.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Antigens, CD; Apyrase; Autoimmune Diseases; Autoimmunity; Gene-Environment Interaction; Humans; Immune Tolerance; Infections; Inflammation; Lymphocyte Activation; Neoplasms; T-Lymphocytes | 2016 |
Disarming suppressor cells to improve immunotherapy.
Topics: 5'-Nucleotidase; Adenosine Monophosphate; Animals; Biomarkers, Tumor; Dinoprostone; Humans; Immunosuppression Therapy; Immunotherapy; Molecular Targeted Therapy; Neoplasms; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Tumor Escape; Tumor Microenvironment | 2012 |
Redox implications of AMPK-mediated signal transduction beyond energetic clues.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Apoptosis; Autophagy; Energy Metabolism; Humans; Mitochondria; Neoplasms; Neurodegenerative Diseases; Oxidation-Reduction; Phosphorylation; Reactive Nitrogen Species; Signal Transduction | 2012 |
AMP-activated protein kinase in metabolic control and insulin signaling.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Adipocytes; Amino Acid Sequence; Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Binding Sites; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Carbohydrate Metabolism; Cell Cycle; Consensus Sequence; Diabetes Mellitus; Energy Metabolism; Enzyme Activation; Hepatocytes; Humans; Hypoglycemic Agents; Insulin; Lipid Metabolism; Metformin; Mice; Mice, Knockout; Models, Molecular; Molecular Sequence Data; Multienzyme Complexes; Muscle Cells; Neoplasms; Obesity; Oxygen Consumption; Peptide Hormones; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Subunits; Rats; Ribonucleotides; Sequence Alignment; Sequence Homology, Amino Acid | 2007 |
Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture.
Topics: Adenosine Monophosphate; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Deoxyribonucleotides; Gene Expression Regulation; Gluconeogenesis; Guanosine Monophosphate; Humans; Inosine Monophosphate; Isoxazoles; Kidney Neoplasms; Liver Neoplasms; Liver Regeneration; Models, Biological; Neoplasms; Purines; Pyrimidines; Ribonucleotides | 1983 |
[Amino acid metabolism and malignant growth].
Topics: Adenosine Monophosphate; Amino Acids; Animals; Deamination; Decarboxylation; Female; Humans; Kinetics; Liver; Male; Mice; Neoplasms; Neoplasms, Experimental; Rats | 1982 |
Enzyme transformations.
Topics: Adenosine Monophosphate; Amine Oxidase (Copper-Containing); Animals; Binding Sites; Enzymes; Esterases; Fructose-Bisphosphatase; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Hydrogen-Ion Concentration; Macromolecular Substances; Mitochondria; Molecular Weight; Monoamine Oxidase; NADH, NADPH Oxidoreductases; Neoplasms; Oxidoreductases Acting on CH-NH Group Donors; Oxygenases; Phosphoric Monoester Hydrolases; Serotonin; Sulfhydryl Compounds; Sulfhydryl Reagents; Xanthine Oxidase | 1977 |
Hypercalcemia in malignancy.
Topics: Adenosine Monophosphate; Bone Resorption; Humans; Hypercalcemia; Neoplasms; Parathyroid Hormone-Related Protein; Proteins | 1990 |
Pasteur effect and phosphofructokinase.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aerobiosis; Ammonia; Anaerobiosis; Animals; Blood Cells; Citrates; Cyclic AMP; Embryo, Mammalian; Embryo, Nonmammalian; Fructosephosphates; Glucose; Glycolysis; Hexokinase; Intestinal Mucosa; Kidney Medulla; Neoplasms; Oxidative Phosphorylation; Oxygen; Oxygen Consumption; Phosphofructokinase-1; Phosphotransferases; Potassium; Pyruvate Kinase; Retina | 1974 |
31 other study(ies) available for adenosine monophosphate and Neoplasms
| Article | Year |
|---|---|
Synthesis and Cytostatic and Antiviral Profiling of Thieno-Fused 7-Deazapurine Ribonucleosides.
Topics: Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Hepacivirus; Hepatitis C; Humans; Neoplasms; Purines; Ribonucleosides | 2017 |
Lanthanide-Nucleotide Coordination Nanoparticles for STING Activation.
Topics: Adenosine Monophosphate; Animals; Europium; Humans; Interferon Type I; Interferon-beta; Lanthanoid Series Elements; Membrane Proteins; Mice; Molecular Docking Simulation; Nanoparticles; Neoplasms; Nucleotides; Nucleotides, Cyclic; Ovalbumin | 2022 |
Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration.
Topics: Adenosine Monophosphate; Cyclic AMP; Endothelial Cells; Humans; Membrane Proteins; Nanoparticles; Neoplasms; Tumor-Associated Macrophages; Zinc | 2022 |
Pharmacology, pharmacokinetics, and toxicity characterization of a novel anti-CD73 therapeutic antibody IBI325 for cancer immunotherapy.
Topics: 5'-Nucleotidase; Adenosine Monophosphate; Animals; Antineoplastic Agents; Humans; Immunotherapy; Mice; Neoplasms | 2023 |
Monitoring and characterizing soluble and membrane-bound ectonucleotidases CD73 and CD39.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Apyrase; Cell Membrane; GPI-Linked Proteins; Humans; Jurkat Cells; Neoplasm Proteins; Neoplasms; Solubility | 2019 |
Luciferase-assisted detection of extracellular ATP and ATP metabolites during immunogenic death of cancer cells.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Membrane Permeability; Extracellular Space; Humans; Immunogenic Cell Death; Luciferases; Membrane Transport Proteins; Mice; Neoplasms; Primary Cell Culture; Pyroptosis; Rats | 2019 |
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
Topics: Adenosine Monophosphate; Age Factors; Aged; Alanine; Betacoronavirus; Clinical Decision-Making; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Drug Utilization; Follow-Up Studies; Glucocorticoids; Healthcare Disparities; Hospital Mortality; Humans; Hydroxychloroquine; Male; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Severity of Illness Index; Sex Factors; Treatment Outcome; United States | 2020 |
Phenformin: AMP(K)ed for Potential Repurposing.
Topics: Adenosine Monophosphate; Drug Repositioning; Humans; Hypoglycemic Agents; Neoplasms; Phenformin | 2021 |
Research shows racial disparity, mortality data for patients with cancer and COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Black or African American; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Healthcare Disparities; Humans; Hydroxychloroquine; Mortality; Neoplasms; Race Factors; United Kingdom; United States | 2021 |
Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors.
Topics: Adenosine Monophosphate; Aged; Alanine; Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; COVID-19 Serotherapy; Dexamethasone; Drug Combinations; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydroxychloroquine; Immunization, Passive; Immunotherapy; Latent Infection; Lopinavir; Lung Neoplasms; Male; Molecular Targeted Therapy; Neoplasms; Proportional Hazards Models; Risk Factors; Ritonavir; SARS-CoV-2; Spain; Time Factors; Virus Shedding | 2021 |
Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country.
Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Child; Child, Preschool; COVID-19; Developing Countries; Female; Humans; Infant; Male; Neoplasms; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome | 2021 |
Extracellular cyclic adenosine monophosphate-dependent protein kinase A autoantibody and C-reactive protein as serum biomarkers for diagnosis of cancer in dogs.
Topics: Adenosine Monophosphate; Animals; Autoantibodies; Biomarkers, Tumor; C-Reactive Protein; Cyclic AMP-Dependent Protein Kinases; Dog Diseases; Dogs; Female; Male; Neoplasms | 2019 |
The first CD73-instructed supramolecular hydrogel.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Cell Survival; GPI-Linked Proteins; HeLa Cells; Hep G2 Cells; Humans; Hydrogels; MCF-7 Cells; Nanofibers; Neoplasms | 2015 |
Serine Metabolism Supports the Methionine Cycle and DNA/RNA Methylation through De Novo ATP Synthesis in Cancer Cells.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Cell Line, Tumor; Colorectal Neoplasms; DNA Methylation; Homocysteine; Humans; Methionine; Neoplasms; RNA; S-Adenosylmethionine; Serine; Stress, Physiological | 2016 |
AMPK-sensed cellular energy state regulates the release of extracellular Fatty Acid Synthase.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antibodies, Monoclonal; Cell Line, Tumor; Culture Media, Conditioned; Cytosol; Energy Metabolism; Fatty Acid Synthase, Type I; Humans; Isoenzymes; Neoplasms; Ribonucleotides; RNA, Small Interfering | 2009 |
2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Amides; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Blood Glucose; Carboxylic Acids; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activation; Female; Humans; Inhibitory Concentration 50; Injections, Intravenous; Male; Mice; Mice, Inbred ICR; Mice, Nude; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazolidines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2010 |
Astrocyte elevated gene-1 induces protective autophagy.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Adenylate Kinase; Autophagy; Autophagy-Related Protein 5; Cell Adhesion Molecules; Cell Line, Transformed; Drug Resistance, Neoplasm; Humans; Male; Membrane Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasms; Pyrazoles; Pyrimidines; RNA-Binding Proteins; TOR Serine-Threonine Kinases | 2010 |
Chemotherapy of canine cancer with N-(3-oxapentamethylene)-N', N''-diethylenephosphoramide (MEPA).
Topics: Adenosine Monophosphate; Amides; Anesthetics, Local; Animals; Dog Diseases; Dogs; Neoplasms | 1956 |
Adenylic acid deaminase activity in spectrum of rat tumors and in normal liver.
Topics: Adenosine Monophosphate; Amidohydrolases; Animals; Liver; Liver Neoplasms; Neoplasms; Rats | 1959 |
Enzymatic deamination of deoxyadenylic and adenylic acids by normal and cancerous rat liver tissues.
Topics: Adenine Nucleotides; Adenosine Monophosphate; Deamination; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Neoplasms; Nucleosides; Nucleotides; Phosphoric Monoester Hydrolases; Sarcoma; Sarcoma, Experimental | 1961 |
Adenylic acid and adenosine deaminase activities in rat livers during azo-dye carcinogenesis.
Topics: Adenosine Deaminase; Adenosine Monophosphate; Amidohydrolases; Carcinogenesis; Liver; Neoplasms; Organic Chemicals | 1959 |
[Metabolism of adenylic acid in the blood of female subjects of malignant genital neoplasms].
Topics: Adenosine Monophosphate; Blood; Genitalia; Genitalia, Female; Neoplasms; Nucleotides | 1955 |
Studies on the mechanism of protein synthesis in embryonic and tumor tissues. II. Inactivation of fetal rat liver homogenates by dialysis, and reactivation by the adenylic acid system.
Topics: Adenosine Monophosphate; Animals; Fetus; Liver; Neoplasms; Protein Biosynthesis; Proteins; Rats; Renal Dialysis | 1950 |
Therapeutic assays of the skin and cancer unit of the New York University Hospital. Assay VI. Adenosine-5-monophosphate (MY-B-DEN) for the relief of pruritus.
Topics: Adenosine; Adenosine Monophosphate; Hospitals, University; Humans; Neoplasms; New York; Pruritus; Skin | 1951 |
MTAP homozygous deletion: an Achilles heel of human cancers ready for clinical use?
Topics: Adenosine Monophosphate; Alanine; Antibiotics, Antineoplastic; Clinical Trials as Topic; Drug Resistance, Neoplasm; Gene Deletion; Homozygote; Humans; Neoplasms; Purine-Nucleoside Phosphorylase | 2005 |
In vitro evaluation of adenosine 5'-monophosphate as an imaging agent of tumor metabolism.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Caffeine; Carbon Radioisotopes; Cell Line, Tumor; Female; Humans; Immunophenotyping; In Vitro Techniques; Models, Biological; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Time Factors | 2006 |
Growth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5'-triphosphate.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Agar; Cell Division; Cell Line; Cell Survival; Culture Media; DNA Replication; Humans; Neoplasms | 1983 |
Phase I study of N6-benzyladenosine-5'-monophosphate.
Topics: Adenosine Monophosphate; Aged; Antineoplastic Agents; Carcinoma; Drug Evaluation; Humans; Liver; Male; Neoplasms; Sarcoma | 1978 |
9-beta-D-arabinofuranosyladenine 5'-phosphate metabolism and excretion in humans.
Topics: Adenocarcinoma; Adenosine Monophosphate; Aged; Carcinoma; Female; Gastrointestinal Neoplasms; Humans; Injections, Intravenous; Male; Melanoma; Middle Aged; Neoplasms; Time Factors; Vidarabine | 1975 |
Synthesis and biological properties of purine and pyrimidine 5'-deoxy-5'-(dihydroxyphosphinyl)-beta-D-ribofuranosyl analogues of AMP, GMP, IMP, and CMP.
Topics: Adenosine Monophosphate; Animals; Chemical Phenomena; Chemistry; Colonic Neoplasms; Cytidine Monophosphate; Cytosine Nucleotides; Guanine Nucleotides; Guanosine Monophosphate; Humans; Inosine Monophosphate; Inosine Nucleotides; Leukemia; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Neoplasms; Phosphorylation; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Tumor Cells, Cultured; Viruses | 1989 |
General introduction to the chalone concept.
Topics: Adenosine Monophosphate; Adenosine Triphosphatases; Cell Count; Demecolcine; Growth Inhibitors; Kinetics; Mitosis; Neoplasms; Nucleotidases; Thymidine; Tritium; Vinblastine | 1973 |